FENC vs UBER · rev $44.6M vs P/E 18, rev $52.02B
Fennec Pharmaceuticals Inc (FENC) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported FENC revenue for 2025-12-31 was $44.6M. Net income was -$9.7M. Revenue was down 6.1% from 2024-12-31 to 2025-12-31. FENC currently screens at market cap $302.2M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
FENC currently screens at market cap $302.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the FENC and UBER stock pages for the full models.
Not investment advice.